Cargando…

Feasibility and safety of automated CO(2) angiography in peripheral arterial interventions

Carbon dioxide (CO(2)) gas is an established alternative to iodine contrast during angiography in patients with risk of postcontrast acute kidney injury and in those with history of iodine contrast allergy. Different CO(2) delivery systems during angiography are reported in literature, with automate...

Descripción completa

Detalles Bibliográficos
Autores principales: Thomas, Rohit Philip, Viniol, Simon, König, Alexander Marc, Portig, Irene, Swaid, Zaher, Mahnken, Andreas H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7808455/
https://www.ncbi.nlm.nih.gov/pubmed/33466210
http://dx.doi.org/10.1097/MD.0000000000024254
_version_ 1783636900802723840
author Thomas, Rohit Philip
Viniol, Simon
König, Alexander Marc
Portig, Irene
Swaid, Zaher
Mahnken, Andreas H.
author_facet Thomas, Rohit Philip
Viniol, Simon
König, Alexander Marc
Portig, Irene
Swaid, Zaher
Mahnken, Andreas H.
author_sort Thomas, Rohit Philip
collection PubMed
description Carbon dioxide (CO(2)) gas is an established alternative to iodine contrast during angiography in patients with risk of postcontrast acute kidney injury and in those with history of iodine contrast allergy. Different CO(2) delivery systems during angiography are reported in literature, with automated delivery system being the latest. The aim of this study is to evaluate the safety, efficacy, and learning curve of an automated CO(2) injection system with controlled pressures in peripheral arterial interventions and also to study the patients’ tolerance to the system. From January 2018 to October 2019 peripheral arterial interventions were performed in 40 patients (median age-78 years, interquartile range: 69–84 years) using an automated CO(2) injection system with customized protocols, with conventional iodine contrast agent used only as a bailout option. The pain and tolerance during the CO(2) angiography were evaluated with a visual analog scale at the end of each procedure. The amount of CO(2), iodine contrast used, and radiation dose area product for the interventions were also systematically recorded for all procedures. These values were statistically compared in 2 groups, viz first 20 patients where a learning curve was expected vs the rest 20 patients. All procedures were successfully completed without complications. All patients tolerated the CO(2) angiography with a median total pain score of 3 (interquartile range: 3–4), with no statistical difference between the groups (P = .529). The 2 groups were statistically comparable in terms of comorbidities and the type of procedures performed (P = .807). The amount of iodine contrast agent used (24.60 ± 6.44 ml vs 32.70 ± 8.70 ml, P = .006) and the radiation dose area product associated were significantly lower in the second group (2160.74 ± 1181.52 μGym(2) vs 1531.62 ± 536.47 μGym(2), P = .043). Automated CO(2) angiography is technically feasible and safe for peripheral arterial interventions and is well tolerated by the patients. With the interventionalist becoming familiar with the technique, better diagnostic accuracy could be obtained using lower volumes of conventional iodine contrast agents and reduction of the radiation dose involved.
format Online
Article
Text
id pubmed-7808455
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-78084552021-01-15 Feasibility and safety of automated CO(2) angiography in peripheral arterial interventions Thomas, Rohit Philip Viniol, Simon König, Alexander Marc Portig, Irene Swaid, Zaher Mahnken, Andreas H. Medicine (Baltimore) 6800 Carbon dioxide (CO(2)) gas is an established alternative to iodine contrast during angiography in patients with risk of postcontrast acute kidney injury and in those with history of iodine contrast allergy. Different CO(2) delivery systems during angiography are reported in literature, with automated delivery system being the latest. The aim of this study is to evaluate the safety, efficacy, and learning curve of an automated CO(2) injection system with controlled pressures in peripheral arterial interventions and also to study the patients’ tolerance to the system. From January 2018 to October 2019 peripheral arterial interventions were performed in 40 patients (median age-78 years, interquartile range: 69–84 years) using an automated CO(2) injection system with customized protocols, with conventional iodine contrast agent used only as a bailout option. The pain and tolerance during the CO(2) angiography were evaluated with a visual analog scale at the end of each procedure. The amount of CO(2), iodine contrast used, and radiation dose area product for the interventions were also systematically recorded for all procedures. These values were statistically compared in 2 groups, viz first 20 patients where a learning curve was expected vs the rest 20 patients. All procedures were successfully completed without complications. All patients tolerated the CO(2) angiography with a median total pain score of 3 (interquartile range: 3–4), with no statistical difference between the groups (P = .529). The 2 groups were statistically comparable in terms of comorbidities and the type of procedures performed (P = .807). The amount of iodine contrast agent used (24.60 ± 6.44 ml vs 32.70 ± 8.70 ml, P = .006) and the radiation dose area product associated were significantly lower in the second group (2160.74 ± 1181.52 μGym(2) vs 1531.62 ± 536.47 μGym(2), P = .043). Automated CO(2) angiography is technically feasible and safe for peripheral arterial interventions and is well tolerated by the patients. With the interventionalist becoming familiar with the technique, better diagnostic accuracy could be obtained using lower volumes of conventional iodine contrast agents and reduction of the radiation dose involved. Lippincott Williams & Wilkins 2021-01-15 /pmc/articles/PMC7808455/ /pubmed/33466210 http://dx.doi.org/10.1097/MD.0000000000024254 Text en Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/)
spellingShingle 6800
Thomas, Rohit Philip
Viniol, Simon
König, Alexander Marc
Portig, Irene
Swaid, Zaher
Mahnken, Andreas H.
Feasibility and safety of automated CO(2) angiography in peripheral arterial interventions
title Feasibility and safety of automated CO(2) angiography in peripheral arterial interventions
title_full Feasibility and safety of automated CO(2) angiography in peripheral arterial interventions
title_fullStr Feasibility and safety of automated CO(2) angiography in peripheral arterial interventions
title_full_unstemmed Feasibility and safety of automated CO(2) angiography in peripheral arterial interventions
title_short Feasibility and safety of automated CO(2) angiography in peripheral arterial interventions
title_sort feasibility and safety of automated co(2) angiography in peripheral arterial interventions
topic 6800
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7808455/
https://www.ncbi.nlm.nih.gov/pubmed/33466210
http://dx.doi.org/10.1097/MD.0000000000024254
work_keys_str_mv AT thomasrohitphilip feasibilityandsafetyofautomatedco2angiographyinperipheralarterialinterventions
AT viniolsimon feasibilityandsafetyofautomatedco2angiographyinperipheralarterialinterventions
AT konigalexandermarc feasibilityandsafetyofautomatedco2angiographyinperipheralarterialinterventions
AT portigirene feasibilityandsafetyofautomatedco2angiographyinperipheralarterialinterventions
AT swaidzaher feasibilityandsafetyofautomatedco2angiographyinperipheralarterialinterventions
AT mahnkenandreash feasibilityandsafetyofautomatedco2angiographyinperipheralarterialinterventions